Literature DB >> 20812037

Dynamics of changes in self-efficacy and locus of control expectancies in the behavioral and drug treatment of severe migraine.

Elizabeth K Seng1, Kenneth A Holroyd.   

Abstract

BACKGROUND: Modification of expectancies (headache self-efficacy and headache locus of control) is thought to be central to the success of psychological treatments for migraine.
PURPOSE: The purpose of this study is to examine expectancy changes with various combinations of Behavioral Migraine Management and migraine drug therapies.
METHODS: Frequent migraine sufferers who failed to respond to 5 weeks of optimized acute migraine drug therapy were randomized to a 2 (Behavioral Migraine Management+, Behavioral Migraine Management-) × 2 (β-blocker, placebo) treatment design.
RESULTS: Mixed models for repeated measures analyses (N = 176) revealed large increases in headache self-efficacy and internal headache locus of control and large decreases in chance headache locus of control with Behavioral Migraine Management+ that were maintained over a 12-month evaluation period. Chance headache locus of control and socioeconomic status moderated changes in headache self-efficacy with Behavioral Migraine Management+.
CONCLUSIONS: The "deficiency" hypothesis best explained how patient characteristics influenced changes in of headache self-efficacy with Behavioral Migraine Management.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812037     DOI: 10.1007/s12160-010-9223-3

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  15 in total

Review 1.  Improving medication adherence in migraine treatment.

Authors:  Elizabeth K Seng; Jeanetta A Rains; Robert A Nicholson; Richard B Lipton
Journal:  Curr Pain Headache Rep       Date:  2015-06

Review 2.  [Psychological therapy of migraine: systematic review].

Authors:  G Fritsche; B Kröner-Herwig; P Kropp; U Niederberger; G Haag
Journal:  Schmerz       Date:  2013-06       Impact factor: 1.107

3.  Headache-Specific Locus of Control and Migraine-Related Quality of Life: Understanding the Role of Anxiety.

Authors:  Amy S Grinberg; Elizabeth K Seng
Journal:  Int J Behav Med       Date:  2017-02

4.  [Relaxation techniques and behavioural therapy for the treatment of migraine : Guidelines from the German Migraine and Headache Society].

Authors:  P Kropp; B Meyer; T Dresler; G Fritsche; C Gaul; U Niederberger; S Förderreuther; V Malzacher; T P Jürgens; M Marziniak; A Straube
Journal:  Schmerz       Date:  2017-10       Impact factor: 1.107

5.  Interventional pain medicine: retreat from the biopsychosocial model of pain.

Authors:  Randy S Roth; Michael E Geisser; David A Williams
Journal:  Transl Behav Med       Date:  2012-03       Impact factor: 3.046

Review 6.  Behavioral treatments for migraine management: useful at each step of migraine care.

Authors:  Alexandra B Singer; Dawn C Buse; Elizabeth K Seng
Journal:  Curr Neurol Neurosci Rep       Date:  2015-04       Impact factor: 5.081

7.  Can weight loss improve migraine headaches in obese women? Rationale and design of the Women's Health and Migraine (WHAM) randomized controlled trial.

Authors:  Dale S Bond; Kevin C O'Leary; J Graham Thomas; Richard B Lipton; George D Papandonatos; Julie Roth; Lucille Rathier; Richard Daniello; Rena R Wing
Journal:  Contemp Clin Trials       Date:  2013-03-22       Impact factor: 2.226

Review 8.  Aerobic Exercise for Reducing Migraine Burden: Mechanisms, Markers, and Models of Change Processes.

Authors:  Megan B Irby; Dale S Bond; Richard B Lipton; Barbara Nicklas; Timothy T Houle; Donald B Penzien
Journal:  Headache       Date:  2015-12-08       Impact factor: 5.887

9.  Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine.

Authors:  Kobina K Hagan; Wenyuan Li; Elizabeth Mostofsky; Suzanne M Bertisch; Angeliki Vgontzas; Catherine Buettner; Murray A Mittleman
Journal:  Headache       Date:  2020-12-21       Impact factor: 5.887

10.  Behavioural management of migraine.

Authors:  Helen Brown; Craig Newman; Rupert Noad; Stuart Weatherby
Journal:  Ann Indian Acad Neurol       Date:  2012-08       Impact factor: 1.383

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.